Nephrogenic Systemic Fibrosis Lawsuits

A nephrogenic systemic fibrosis (NSF) lawsuit is a personal injury case in which patients who develop nephrogenic systemic fibrosis seek compensation for their medical bills, permanent disabilities and emotional pain and suffering.

Nephrogenic systemic fibrosis is an incurable condition in which the connective tissue in the joints, skin, eyes and internal organs begins developing debilitating fibrous cells. As the condition progresses, it causes severe pain and can significantly impair movement.

Causes of Nephrogenic Systemic Fibrosis

The precise causes of nephrogenic systemic fibrosis are currently unknown. However, as researchers continue their studies, they are finding links between the development of NSF and:

  • Use of immunosuppressant medications (which are prescribed in the treatment of hepatitis C, psoriasis and certain types of cancer)
  • Exposure to gadolinium, the active ingredient in various MRI dyes (Gadolinium is a silvery-white metallic element that is known to be mildly to moderately toxic)

Injected immediately before an MRI scan, MRI contrast dyes will highlight the structure and/or function of organ(s) in the result image. Brand names of commonly used gadolinium MRI contrast agents include:

  • Magnevist
  • Multihance
  • Omniscan
  • OptiMARK

Patients with the highest risk of developing nephrogenic systemic fibrosis include those with a history of kidney disorders (particularly kidney failure).

Other Gadolinium Side Effects

Currently, the full range of gadolinium side effects is unknown. However, to date, most serious gadolinium side effect is nephrogenic systemic fibrosis. Other known gadolinium side effects may include:

  • blood clots
  • headache
  • hypotension (dangerously low blood pressure)
  • lightheadedness
  • nausea
  • severe allergic reaction (characterized by skin rash, breathing difficulties and facial or tongue inflammation)

Nephrogenic Systemic Fibrosis Treatments

Because there is currently no cure for NSF, treatments for nephrogenic systemic fibrosis involve:

  • preventing the condition from progressing
  • minimizing a patient's symptoms by reducing pain and improving mobility

To this end, treatment options for nephrogenic systemic fibrosis may include:

  • anti-inflammatory drugs
  • deep tissue massages
  • physical therapy
  • regular exercise (such as swimming, yoga or other low-impact activities)
  • steroids
  • topical creams (particularly Dovonex, generically known as calcipotriene)

Starting and Winning a Nephrogenic Systemic Fibrosis Lawsuit

Once patients are diagnosed with nephrogenic systemic fibrosis, it's vital that they not only follow through with all prescribed treatments to prevent worsened symptoms, but also meet with an experienced nephrogenic systemic fibrosis lawyer to find out if they are entitled to compensation for their injuries.

During a free initial consultation, nephrogenic systemic fibrosis attorneys will provide prospective plaintiffs with expert advice regarding the best manner in which to proceed with their case. By pursuing a NSF lawsuit, patients will be able to seek the compensation they need to continue the best possible treatment for their condition.

Although the process of winning a nephrogenic systemic fibrosis lawsuit can take months, those who stand up for their legal rights and follow through with their claim can win compensation for their:

  • past hospital bills
  • ongoing treatment costs
  • lost wages
  • future living costs
  • permanent disabilities
  • pain and suffering

More Information About NSF Lawsuits

If you or a loved one has been diagnosed with NSF it important to start a legal claim immediately. For more information and to schedule a free, confidential consultation contact a nephrogenic systemic fibrosis attorney today. We will evaluate your case and provide you and your family with the compassion and commitment we would expect for our own families.

Enter Content Here

Gadolinium Contrast Agents Required to Include New Warning

The U.S. Food and Drug Administration (FDA) issued a news release Sept. 9, 2010, requiring that contrast agents containing gadolinium carry a new warning on their labels because it can lead to nephrogenic systemic fibrosis (NSF). Read More »

First Gadolinium Lawsuit Filed in U.S. Court

An Ohio woman has filed what is believed to be the first gadolinium lawsuit, claiming that the MRI dye Magnevist-made by Bayer-caused her 24-year-old son's death.
Read More »

Gadolinium-Based MRI Dyes Get Black Box Warning

The Food and Drug Administration has asked that a black box warning be added to all gadolinium-based MRI dyes to highlight the risk of nephrogenic systemic fibrosis, or NSF.
Read More »